Correction: Equid Herpesvirus Type 1 Activates Platelets.

Summary

# Editorial Summary: Equid Herpesvirus Type 1 and Platelet Activation Equid herpesvirus type 1 (EHV-1) represents a significant clinical challenge in equine practice, and understanding its interaction with the immune system is crucial for developing targeted interventions. Stokol and colleagues investigated how EHV-1 directly activates equine platelets—key players in both haemostasis and immune response—using in vitro platelet aggregation assays and flow cytometric analysis to measure platelet activation markers following viral exposure. The research established that EHV-1 can directly stimulate platelet activation, independent of other immune cells, a finding with potential implications for the thrombotic and inflammatory complications observed in naturally infected horses, particularly those experiencing vasculitis or neurological disease. This mechanistic insight suggests that platelet dysfunction may contribute to the severe systemic manifestations seen in some EHV-1 cases and could inform future research into antiplatelet or anticoagulant therapies as adjunctive treatments. For practitioners managing EHV-1 outbreaks or treating affected horses, these findings underscore the importance of monitoring for coagulation abnormalities and considering haematological complications as part of the disease process rather than coincidental findings.

Read the full abstract on PubMed

Key Findings

• •This is a correction notice to a previously published study on EHV-1 and platelet activation

Conditions Studied